Identification and quantification of drugs in human amniotic fluid.
Since drugs administered to gravid females are rapidly transferred to the fetus, transplacentally acquired drugs and drug metabolities should be excreted by the fetus into amniotic fluid. Analyses have been carried out on amniotic fluid obtained at the time of delivery using a gas chromatograph-mass spectrometer-computer system. The drugs that have been identified are caffeine, secobarbital and phenobarbital. Theobromine (3,7-dimethylxanthine) and smaller amounts of 1,7- and 1,3-dimethylxanthine, three metabolites of caffeine, were also found in amniotic fluid, but metabolites of secobarbital and phenobarbital were not detected. It is known that human fetal tissues have active enzyme systems for metabolizing drugs, but these results suggest that this may be a selective rather than general occurence.
D000653:Amniotic Fluid / Q000032:analysis*; D002110:Caffeine / Q000032:analysis / Q000097:blood; D002849:Chromatography, Gas; D003201:Computers; D005260:Female; D005312:Fetal Blood / Q000032:analysis; D006801:Humans; D013058:Mass Spectrometry; D008431:Maternal-Fetal Exchange; D004364:Pharmaceutical Preparations / Q000032:analysis* / Q000097:blood; D010634:Phenobarbital / Q000032:analysis; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D012631:Secobarbital / Q000032:analysis; D013805:Theobromine / Q000032:analysis / Q000097:blood
D004364:Pharmaceutical Preparations; D012631:Secobarbital; D002110:Caffeine; D013805:Theobromine; D010634:Phenobarbital